Non-Invasive Prenatal Testing (NIPT)

NIPT, also known as cell-free DNA (cfDNA) screening, examines tiny fragments of DNA that leak from the placenta into the maternal bloodstream. These fragments are called 'cell-free' because they circulate outside cells. Around 10–15% of the cfDNA in a pregnant woman's blood comes from the pregnancy (the 'fetal fraction'), while the rest is maternal.

By counting these fragments and comparing them to a normal reference set, laboratories can identify if there is a higher probability of genetic material differences. For instance, an atypical amount of chromosome 21 fragments indicates a high probability of Down syndrome. NIPT is a screening test, not a diagnostic test, because it analyzes DNA originating from the placenta (which usually, but not always, matches the baby's DNA). In rare instances, chromosomal abnormalities may exist only in the placenta—a condition known as confined placental mosaicism—leading to a false-positive result. At our Unit, we utilize advanced Next-Generation Sequencing (NGS) platforms to ensure highly reliable results while ensuring you understand the screening nature of the test.

Screening and diagnostic options should be discussed with every pregnant patient, regardless of age. Whether NIPT is the right choice depends on what you want to know, your scan findings, previous results and the laboratory's scope.

A known family genetic condition or an ultrasound abnormality may call for targeted genetic advice or diagnostic testing rather than standard NIPT. Tell the team about previous affected pregnancies and share any available genetic reports.

You may choose or decline screening after discussing its benefits and limitations. Ultrasound remains important even when NIPT gives a low-chance result.

The clinical pathway for NIPT at our Maternal Fetal Medicine Unit is simple and structured:

1. Pre-test Counselling: You will meet with our team to discuss what NIPT can and cannot reveal, ensuring you understand that NIPT is a screening test, not a diagnostic test.
2. Blood Draw: A standard maternal blood sample is taken. Because it does not enter the pregnancy, it does not add a procedure-related miscarriage risk. No fasting is required.
3. Laboratory Analysis: The sample is analyzed to measure the fetal fraction and evaluate chromosomal balances.
4. The Report: The laboratory classifies results as low probability or high probability for the specific chromosomes tested; turnaround time depends on the selected laboratory.

Your pregnancy care path is planned based on the clinical correlation of all screening results, including NIPT and ultrasound:

• Low Probability (Low Risk): This indicates a very low likelihood of the tested chromosomal conditions. While reassuring, it does not guarantee a normal baby. Care continues with routine anatomy ultrasounds.
• High Probability (High Risk): A high-risk NIPT result is not a definitive diagnosis. It indicates a significantly increased probability. If a high-risk result is obtained, it should be discussed immediately with a fetal medicine or genetics specialist.
• Confirmatory Testing: To obtain a definitive diagnosis, confirmatory diagnostic testing (CVS or amniocentesis) is recommended. No irreversible decisions regarding the pregnancy should be made based on a screening result alone.

Integrating NIPT with high-resolution ultrasound screening helps families make informed choices while significantly reducing the need for invasive diagnostic procedures.

However, a low-risk NIPT result must never replace detailed ultrasound scans. Ultrasound remains vital because it screens for structural anomalies (like heart defects or spina bifida) and fetal growth restriction, which NIPT cannot detect. Our unit specializes in managing complex screening results, including twin pregnancies, high BMI cases, and inconclusive (no-call) reports, translating genetic probabilities into a safe clinical care path.

If you receive a high-risk NIPT result, an inconclusive (no-call) report, or have concerns about your screening outcomes, you should consult a Maternal Fetal Medicine specialist immediately.

Our specialists provide expert counselling, detailed ultrasound correlation, and direct access to confirmatory diagnostic tests (CVS and amniocentesis). We act as a trusted tertiary referral hub in the UAE, ensuring you receive clear explanations, compassionate support, and precise diagnostic pathways.